Literature DB >> 24022843

Prostate volume correlates with diabetes in elderly benign prostatic hyperplasia patients.

Xiaobing Qu, Zhichao Huang, Xianqin Meng, Xiangyu Zhang, Lini Dong, Xiaokun Zhao.   

Abstract

BACKGROUND: To evaluate the relationship between prostate volume (PV) and diabetes mellitus (DM) in geriatric benign prostatic hyperplasia (BPH) patients.
METHODS: One hundred and seventeen geriatric patients with BPH were retrospectively studied between 2008 and 2009. Patients were divided into two groups: BPH and BPH with DM group. The effects of indexes of DM, including fasting blood glucose (FBG), 2-h postprandial blood glucose, glycosylated hemoglobin (HbA1c), fasting insulin (FINS), insulin resistance (IR) index, prostate-specific antigen (PSA), International Prostate Symptom Score (IPSS), and lower urinary tract symptoms (LUTS) were evaluated.
RESULTS: The values of PV (P = 0.005), PSA (P = 0.013), and IPSS (P = 0.01) in the BPH patients with DM group were significantly higher than in the BPH group. The values of PV (P = 0.002) and PSA (P = 0.006) in the BPH patients with elevated FBG were significantly higher than in the BPH patients with normal FBG. BPH patients with elevated HbA1c had significantly higher PV than BPH patients with normal HbA1c (P = 0.046). BPH with hyperinsulinemia group showed significantly higher PV (P = 0.017) and longer duration of LUTS (P = 0.031) than BPH patients with normal FINS. Similarly, BPH patients with IR had higher PV (P = 0.004) and longer duration of LUTS (P = 0.036) than BPH patients without IR. The logistic regression analysis showed that FBG and FINS were the risk factors for BPH.
CONCLUSIONS: Our study demonstrates that PV is closely correlated with diabetes and diabetes has a direct effect on the occurrence and development of BPH.

Entities:  

Mesh:

Year:  2014        PMID: 24022843     DOI: 10.1007/s11255-013-0555-3

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  18 in total

1.  Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia.

Authors:  Sara E Dahle; Anand P Chokkalingam; Yu-Tang Gao; Jie Deng; Frank Z Stanczyk; Ann W Hsing
Journal:  J Urol       Date:  2002-08       Impact factor: 7.450

Review 2.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

3.  The accuracy of transrectal ultrasound prostate volume estimation: clinical correlations.

Authors:  G J Matthews; J Motta; J A Fracehia
Journal:  J Clin Ultrasound       Date:  1996 Nov-Dec       Impact factor: 0.910

4.  Economic issues and the management of benign prostatic hyperplasia.

Authors:  H L Holtgrewe
Journal:  Urology       Date:  1995-09       Impact factor: 2.649

5.  Hypertension, diabetes mellitus, and blood groups in benign prostatic hypertrophy.

Authors:  J B Bourke; J P Griffin
Journal:  Br J Urol       Date:  1966-02

6.  Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.

Authors:  J Hammarsten; B Högstedt
Journal:  Eur Urol       Date:  2001-02       Impact factor: 20.096

7.  EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

Authors:  Stephan Madersbacher; Gerasimos Alivizatos; Jorgen Nordling; Carlos Rioja Sanz; Mark Emberton; Jean J M C H de la Rosette
Journal:  Eur Urol       Date:  2004-11       Impact factor: 20.096

Review 8.  Hyperinsulinemia and atherosclerosis.

Authors:  E Standl
Journal:  Clin Invest Med       Date:  1995-08       Impact factor: 0.825

9.  Increased cell proliferation and contractility of prostate in insulin resistant rats: linking hyperinsulinemia with benign prostate hyperplasia.

Authors:  A Vikram; G B Jena; P Ramarao
Journal:  Prostate       Date:  2010-01-01       Impact factor: 4.104

10.  Obesity and benign prostatic hyperplasia.

Authors:  E Giovannucci; E B Rimm; C G Chute; I Kawachi; G A Colditz; M J Stampfer; W C Willett
Journal:  Am J Epidemiol       Date:  1994-12-01       Impact factor: 4.897

View more
  12 in total

1.  An inverse association of body mass index and prostate-specific antigen in northwest men of China: a population-based analysis.

Authors:  Jianqin Zhang; Binwu Sheng; Mao Ma; Xunyi Nan
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse.

Authors:  LaTayia M Aaron-Brooks; Takeshi Sasaki; Renee E Vickman; Lin Wei; Omar E Franco; Yuan Ji; Susan E Crawford; Simon W Hayward
Journal:  Prostate       Date:  2019-04-18       Impact factor: 4.104

3.  The association of new-onset diabetes mellitus and medical therapy for benign prostatic hyperplasia: A population-based study.

Authors:  Jeannette Johnstone; Avril Lusty; Mina Tohidi; Marlo Whitehead; Joan Tranmer; J Curtis Nickel; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2021-08       Impact factor: 1.862

Review 4.  Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.

Authors:  Benjamin N Breyer; Aruna V Sarma
Journal:  Curr Urol Rep       Date:  2014-12       Impact factor: 3.092

5.  Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?

Authors:  Aleksandra Rył; Iwona Rotter; Tomasz Miazgowski; Marcin Słojewski; Barbara Dołęgowska; Anna Lubkowska; Maria Laszczyńska
Journal:  Diabetol Metab Syndr       Date:  2015-10-29       Impact factor: 3.320

6.  Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China.

Authors:  J Zhang; M Ma; X Nan; B Sheng
Journal:  Braz J Med Biol Res       Date:  2016-07-11       Impact factor: 2.590

7.  High glucose induces the proliferation of prostatic cells via downregulating MRE11.

Authors:  Chunwei Ye; Yi Cai; Qian Cai; Shunhui Yuan; Fan Huang; Xiaofang Yang; Shuchen He; Zhuoheng Li; Yanwen Wang; Delin Yang; Zhipeng Li
Journal:  Int J Mol Med       Date:  2018-03-07       Impact factor: 4.101

8.  Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia Patients.

Authors:  Emadoddin Moudi; Abazar Akbarzadeh-Pasha
Journal:  Caspian J Intern Med       Date:  2017

9.  The effectiveness of electrical stimulation for the management of benign prostatic hyperplasia: A protocol for systematic review and meta analysis.

Authors:  Wei-Jun Han; Yu-Ge Guo; Yun-Qi Wang; Jin-Wan Wang
Journal:  Medicine (Baltimore)       Date:  2020-05       Impact factor: 1.889

10.  Association of a Missense ALDH2 Single Nucleotide Polymorphism (Glu504Lys) With Benign Prostate Hyperplasia in a Korean Population.

Authors:  Hosik Seok; Koo Han Yoo; Young Ock Kim; Joo-Ho Chung
Journal:  Int Neurourol J       Date:  2013-12-31       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.